Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för marinobufagenin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2019-12-26

Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.

Macdonald LE, Meagher KA, Franklin MC, Levenkova N, Hansen J, Badithe AT, Zhong M, Krueger P, Rafique A, Tu N, Shevchuk J, Wadhwa S, Ehrlich G, Bautista J, Grant C, Esau L, Poueymirou WT, Auerbach W, Morton L, Babb R, Chen G, Huang T, MacDonald D, Graham K, Gurer C, Voronina VA, McWhirter JR, Guo C, Yancopoulos GD, Murphy AJ.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1073/pnas.1901734117

Bibliografisk träff 2019-05-20

Marinobufagenin Inhibits Neutrophil Migration and Proinflammatory Cytokines.

Carvalho DCM, Cavalcante-Silva LHA, Lima ÉA, Galvão JGFM, Alves AKA, Feijó PRO, Quintas LEM, Rodrigues-Mascarenhas S.

J Immunol Res · research-article; journal article · DOI 10.1155/2019/1094520

Bibliografisk träff 2019-02-28

The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.

Keppel MH, Piecha G, März W, Cadamuro J, Auer S, Felder TK, Mrazek C, Oberkofler H, Trummer C, Grübler MR, Schwetz V, Verheyen N, Pandis M, Borzan V, Haschke-Becher E, Tomaschitz A, Pilz S.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0212973

Bibliografisk träff 2018-12-01

Large artery stiffness is associated with marinobufagenin in young adults: the African-PREDICT study.

Strauss M, Smith W, Wei W, Bagrov AY, Fedorova OV, Schutte AE.

J Hypertens · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article · DOI 10.1097/hjh.0000000000001866

Bibliografisk träff 2018-07-11

Marinobufagenin and left ventricular mass in young adults: The African-PREDICT study.

Strauss M, Smith W, Kruger R, Wei W, Fedorova OV, Schutte AE.

Eur J Prev Cardiol · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article · DOI 10.1177/2047487318788140

Bibliografisk träff 2018-05-07

Revealing of endogenous Marinobufagin by an ultra-specific and sensitive UHPLC-MS/MS assay in pregnant women.

Lenaerts C, Bond L, Tuytten R, Blankert B.

Talanta · journal article · DOI 10.1016/j.talanta.2018.05.020

Bibliografisk träff 2005-05-01

Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens.

Cunha Filho GA, Schwartz CA, Resck IS, Murta MM, Lemos SS, Castro MS, Kyaw C, Pires OR, Leite JR, Bloch C, Schwartz EF.

Toxicon · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.toxicon.2005.01.017

Bibliografisk träff 2002-03-01

Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.

Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY.

Circulation · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1161/hc0902.104710